600267 海正药业
已收盘 11-06 15:00:00
资讯
新帖
简况
股市必读：海正药业新发布《浙江海正药业股份有限公司关于召开2026年第三季度业绩说明会的公告》
证券之星 · 11-04
股市必读：海正药业新发布《浙江海正药业股份有限公司关于召开2026年第三季度业绩说明会的公告》
海正药业（600267）披露2026年第三季度业绩说明会安排，11月02日股价下跌0.39%
证券之星 · 11-02
海正药业（600267）披露2026年第三季度业绩说明会安排，11月02日股价下跌0.39%
海正药业（600267）2026年三季报简析：净利润同比增长148.56%，盈利能力上升
证券之星 · 10-30
海正药业（600267）2026年三季报简析：净利润同比增长148.56%，盈利能力上升
10月29日海正药业跌5.07%，大摩优悦安和混合A基金重仓该股
证券之星 · 10-29
10月29日海正药业跌5.07%，大摩优悦安和混合A基金重仓该股
海正药业(600267)9月30日股东户数5.6万户，较上期增加14.7%
证券之星 · 10-28
海正药业(600267)9月30日股东户数5.6万户，较上期增加14.7%
海正药业最新公告：前三季度净利润同比增长148.56%
证券之星 · 10-27
海正药业最新公告：前三季度净利润同比增长148.56%
10月21日海正药业涨5.12%，大成丰享回报混合A基金重仓该股
证券之星 · 10-21
10月21日海正药业涨5.12%，大成丰享回报混合A基金重仓该股
海正药业（600267）10月20日主力资金净买入1.13亿元
证券之星 · 10-21
海正药业（600267）10月20日主力资金净买入1.13亿元
异动快报：海正药业（600267）10月20日9点33分触及涨停板
证券之星 · 10-20
异动快报：海正药业（600267）10月20日9点33分触及涨停板
海正药业发布前三季度经营数据 主业盈利能力稳步提升
东方财富网 · 10-19
海正药业发布前三季度经营数据 主业盈利能力稳步提升
10月19日海正药业涨10.04%，大成丰享回报混合A基金重仓该股
证券之星 · 10-19
10月19日海正药业涨10.04%，大成丰享回报混合A基金重仓该股
股市必读：海正药业（600267）预计2026年1-9月营业收入65.2亿元
证券之星 · 10-19
股市必读：海正药业（600267）预计2026年1-9月营业收入65.2亿元
海正药业（600267）披露2026年前三季度经营数据，10月16日股价下跌1.88%
证券之星 · 10-16
海正药业（600267）披露2026年前三季度经营数据，10月16日股价下跌1.88%
海正药业：预计2026年1-9月归属净利润盈利约11.5亿元
证券之星 · 10-16
海正药业：预计2026年1-9月归属净利润盈利约11.5亿元
海正药业（600267）披露完成工商变更登记并换发营业执照公告，10月13日股价下跌1.62%
证券之星 · 10-13
海正药业（600267）披露完成工商变更登记并换发营业执照公告，10月13日股价下跌1.62%
股市必读：海正药业新发布《浙江海正药业股份有限公司关于子公司获得兽药产品批准文号批件的公告》
证券之星 · 10-12
股市必读：海正药业新发布《浙江海正药业股份有限公司关于子公司获得兽药产品批准文号批件的公告》
海正药业（600267）披露子公司获得兽药产品批准文号批件，10月9日股价上涨2.58%
证券之星 · 10-09
海正药业（600267）披露子公司获得兽药产品批准文号批件，10月9日股价上涨2.58%
股市必读：海正药业新发布《简式权益变动报告书（金浦浙展）》
证券之星 · 09-29
股市必读：海正药业新发布《简式权益变动报告书（金浦浙展）》
海正药业（600267）披露持股5%以上股东协议转让股份提示性公告，9月28日股价上涨0.96%
证券之星 · 09-28
海正药业（600267）披露持股5%以上股东协议转让股份提示性公告，9月28日股价上涨0.96%
股市必读：海正药业新发布《简式权益变动报告书（金浦浙展）》
证券之星 · 09-28
股市必读：海正药业新发布《简式权益变动报告书（金浦浙展）》
加载更多
公司概况
公司名称：
浙江海正药业股份有限公司
所属行业：
医药制造业
上市日期：
2000-07-25
主营业务：
浙江海正药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是海博麦布片（赛斯美）、注射用哌拉西林钠他唑巴坦钠（特治星）、盐酸米诺环素胶囊（玫满）、茚达特罗格隆溴铵吸入粉雾剂（杰润）、注射用丝裂霉素、瑞舒伐他汀钙片（海舒严）、注射用亚胺培南西司他丁钠（俊特）、米尔贝肟吡喹酮片（海乐妙）、丁二磺酸腺苷蛋氨酸肠溶片（喜美欣）、英夫马芬净。
发行价格：
11.83
{"stockData":{"symbol":"600267","market":"SH","secType":"STK","nameCN":"海正药业","latestPrice":13.4,"timestamp":1793948400000,"preClose":13.83,"halted":0,"volume":32588930,"delay":0,"changeRate":-0.0311,"floatShares":1180000000,"shares":1180000000,"eps":1.0384,"marketStatus":"已收盘","change":-0.43,"latestTime":"11-06 15:00:00","open":13.38,"high":13.68,"low":13.25,"amount":438000000,"amplitude":0.0311,"askPrice":13.41,"askSize":264,"bidPrice":13.4,"bidSize":323,"shortable":0,"etf":0,"ttmEps":1.0384,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":13.83,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":15.21,"lowLimit":12.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1180272096,"isCdr":false,"pbRate":1.66,"roa":"--","peRate":12.904468,"roe":"12.67%","epsLYR":0.46,"committee":0.280153,"marketValue":15816000000,"turnoverRate":0.0276,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-09。","floatMarketCap":15816000000},"requestUrl":"/m/hq/s/600267","defaultTab":"news","newsList":[{"id":"2680777548","title":"股市必读：海正药业新发布《浙江海正药业股份有限公司关于召开2026年第三季度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680777548","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680777548?lang=zh_cn&edition=full","pubTime":"2026-11-04 01:05","pubTimestamp":1793725508,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，海正药业报收于12.77元，下跌1.01%，换手率2.28%，成交量26.92万手，成交额3.43亿元。当日关注点交易信息汇总：11月3日主力资金净流入2774.91万元，占总成交额8.09%。公司公告汇总：海正药业将于2026年11月12日15:30-16:30在同花顺路演平台召开2026年第三季度业绩说明会，采用网络在线文字互动方式。公司董事长、总裁肖卫红，独立董事周华俐，高级副总裁兼财务总监蒋灵，董事会秘书赵钱波将出席。说明会结束后可通过该平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400002184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","600267","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680763769","title":"海正药业（600267）披露2026年第三季度业绩说明会安排，11月02日股价下跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680763769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680763769?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:19","pubTimestamp":1793629168,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘，海正药业报收于12.9元，较前一交易日下跌0.39%，最新总市值为152.26亿元。该股当日开盘12.95元，最高13.1元，最低12.6元，成交额达4.32亿元，换手率为2.85%。近日，浙江海正药业股份有限公司发布关于召开2026年第三季度业绩说明会的公告。公告显示，公司将于2026年11月12日15:30-16:30在同花顺路演平台举行2026年第三季度业绩说明会，采用网络在线文字互动方式召开。说明会结束后可通过该平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200036814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0188","BK0239","600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679246878","title":"海正药业（600267）2026年三季报简析：净利润同比增长148.56%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679246878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679246878?lang=zh_cn&edition=full","pubTime":"2026-10-30 23:56","pubTimestamp":1793375788,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海正药业发布2026年三季报。截至本报告期末，公司营业总收入65.21亿元，同比下降17.7%，归母净利润11.46亿元，同比上升148.56%。按单季度数据看，第三季度营业总收入20.45亿元，同比下降23.47%，第三季度归母净利润5.09亿元，同比上升214.61%。本报告期海正药业盈利能力上升，毛利率同比增幅29.84%，净利率同比增幅199.84%。本文数据来源于海正药业2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000059150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679547386","title":"10月29日海正药业跌5.07%，大摩优悦安和混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679547386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679547386?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:37","pubTimestamp":1793263053,"startTime":"0","endTime":"0","summary":"证券之星消息，10月29日海正药业跌5.07%，收盘报12.72元，换手率3.78%，成交量44.66万手，成交额5.78亿元。重仓海正药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为摩根士丹利基金的大摩优悦安和混合A。大摩优悦安和混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900040384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","BK0188","600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678646315","title":"海正药业(600267)9月30日股东户数5.6万户，较上期增加14.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678646315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678646315?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:25","pubTimestamp":1793183127,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海正药业披露，截至2026年9月30日公司股东户数为5.6万户，较6月30日增加7179.0户，增幅为14.7%。在化学制药行业个股中，海正药业股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.9万户。从股价来看，2026年6月30日至2026年9月30日，海正药业区间涨幅为16.22%，在此期间股东户数增加7179.0户，增幅为14.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800039637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0239","BK0028","600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678171939","title":"海正药业最新公告：前三季度净利润同比增长148.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678171939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678171939?lang=zh_cn&edition=full","pubTime":"2026-10-27 19:26","pubTimestamp":1793100360,"startTime":"0","endTime":"0","summary":"海正药业(600267.SH)公告称，第三季度营业收入为20.45亿元，同比下降23.47%；归属于上市公司股东的净利润为5.09亿元，同比增长214.61%。前三季度营业收入为65.21亿元，同比下降17.70%；归属于上市公司股东的净利润为11.46亿元，同比增长148.56%。注：公司Q3净利润5.09亿，Q2净利润2.81亿，据此计算，Q3净利润环比增长81%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700037340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677162915","title":"10月21日海正药业涨5.12%，大成丰享回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677162915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677162915?lang=zh_cn&edition=full","pubTime":"2026-10-21 16:29","pubTimestamp":1792571383,"startTime":"0","endTime":"0","summary":"证券之星消息，10月21日海正药业涨5.12%，收盘报13.95元，换手率12.29%，成交量145.03万手，成交额20.24亿元。重仓海正药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为大成基金的大成丰享回报混合A。大成丰享回报混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100028202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267","BK0028","BK0239","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677610655","title":"海正药业（600267）10月20日主力资金净买入1.13亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677610655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677610655?lang=zh_cn&edition=full","pubTime":"2026-10-21 08:14","pubTimestamp":1792541666,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月20日收盘，海正药业报收于13.27元，上涨10.03%，已连续涨停2天，换手率4.92%，成交量58.09万手，成交额7.7亿元。近5日资金流向一览见下表：海正药业融资融券信息显示，融资方面，当日融资买入1.14亿元，融资偿还1.26亿元，融资净偿还1223.38万元。海正药业主营业务：医药制剂业务,医药原料药业务,动物药业务,医药经销业务,医药制剂进口品及接受药品营销外包业务,新兴业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100006850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0239","BK0028","600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665831","title":"异动快报：海正药业（600267）10月20日9点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665831","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665831?lang=zh_cn&edition=full","pubTime":"2026-10-20 09:36","pubTimestamp":1792460182,"startTime":"0","endTime":"0","summary":"证券之星10月20日盘中消息，9点33分海正药业（600267）触及涨停板。其所属行业化学制药目前下跌。领涨股为海正药业。该股为阿尔茨海默病，宠物经济，医药概念热股，当日阿尔茨海默病概念上涨0.16%，宠物经济概念上涨0.05%。10月19日的资金流向数据方面，主力资金净流入6576.78万元，占总成交额55.57%，游资资金净流出3535.51万元，占总成交额29.87%，散户资金净流出3041.27万元，占总成交额25.7%。近5日资金流向一览见下表：海正药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000007502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0028","BK0188","600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676862556","title":"海正药业发布前三季度经营数据 主业盈利能力稳步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2676862556","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676862556?lang=zh_cn&edition=full","pubTime":"2026-10-19 20:12","pubTimestamp":1792411942,"startTime":"0","endTime":"0","summary":"10月16日，海正药业（600267.SH）发布2026年前三季度经营数据公告。经初步测算，公司预计实现营业收入65.2亿元左右，同比下降17.71%左右；预计实现归属于上市公司股东的净利润11.5亿元左右，同比增长149.46%左右；预计实现扣除非经常性损益后的净利润9.8亿元左右，同比增长99.59%左右。营收下滑与利润增长的反向走势，源于公司年内完成的一笔资产处置。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202610193900072561.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202610193900072561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK0188","BK0028","PSET","600267","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676093425","title":"10月19日海正药业涨10.04%，大成丰享回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676093425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676093425?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:28","pubTimestamp":1792398484,"startTime":"0","endTime":"0","summary":"证券之星消息，10月19日海正药业涨10.04%，收盘报12.06元，换手率0.83%，成交量9.81万手，成交额1.18亿元。重仓海正药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为大成基金的大成丰享回报混合A。大成丰享回报混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900020156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","600267","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676578119","title":"股市必读：海正药业（600267）预计2026年1-9月营业收入65.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676578119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676578119?lang=zh_cn&edition=full","pubTime":"2026-10-19 01:42","pubTimestamp":1792345331,"startTime":"0","endTime":"0","summary":"业绩披露要点业绩预告预计2026年1-9月归属净利润盈利约11.5亿元；营业收入65.2亿元；扣非后净利润盈利约9.8亿元。营收下降主要因完成浙江省医药工业有限公司100%股权转让导致其出表；剔除该影响后，营业收入同比增长7.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675518361","title":"海正药业（600267）披露2026年前三季度经营数据，10月16日股价下跌1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675518361","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675518361?lang=zh_cn&edition=full","pubTime":"2026-10-16 22:33","pubTimestamp":1792161205,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘，海正药业报收于10.96元，较前一交易日下跌1.88%，最新总市值为129.36亿元。该股当日开盘11.24元，最高11.5元，最低10.84元，成交额达3.13亿元，换手率为2.36%。近日，浙江海正药业股份有限公司发布《关于2026年前三季度经营数据的公告》。公告显示，公司预计2026年前三季度实现营业收入65.2亿元左右，同比下降17.71%；归属于上市公司股东的净利润11.5亿元左右，同比增长149.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600040490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267","BK0060","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675593258","title":"海正药业：预计2026年1-9月归属净利润盈利约11.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675593258","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675593258?lang=zh_cn&edition=full","pubTime":"2026-10-16 18:01","pubTimestamp":1792144864,"startTime":"0","endTime":"0","summary":"证券之星消息，海正药业发布业绩预告，预计2026年1-9月归属净利润盈利约11.5亿元。海正药业2026年中报显示，上半年度公司主营收入44.75亿元，同比下降14.76%；归母净利润6.36亿元，同比上升112.82%；扣非净利润5.13亿元，同比上升59.78%；其中2026年第二季度，公司单季度主营收入20.85亿元，同比下降20.37%；单季度归母净利润2.81亿元，同比上升167.81%；单季度扣非净利润2.77亿元，同比上升99.55%；负债率31.84%，投资收益1.76亿元，财务费用3133.85万元，毛利率55.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600031208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675368525","title":"海正药业（600267）披露完成工商变更登记并换发营业执照公告，10月13日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675368525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675368525?lang=zh_cn&edition=full","pubTime":"2026-10-13 22:26","pubTimestamp":1791901580,"startTime":"0","endTime":"0","summary":"近日，浙江海正药业股份有限公司发布《关于完成工商变更登记并换发营业执照的公告》。公告显示，公司于2026年4月3日召开第十届董事会第十四次会议，并于2026年4月28日召开2025年年度股东会，审议通过了关于变更注册资本、修订《公司章程》及办理工商变更登记的议案。近日，公司已完成相关工商变更登记及修订后《公司章程》的备案手续，并取得浙江省市场监督管理局换发的《营业执照》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300040014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600267","BK0188","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674845682","title":"股市必读：海正药业新发布《浙江海正药业股份有限公司关于子公司获得兽药产品批准文号批件的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674845682","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674845682?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:06","pubTimestamp":1791741977,"startTime":"0","endTime":"0","summary":"公司公告汇总：子公司获替米沙坦内服溶液（猫用）兽药产品批准文号，有效期至2031年10月7日，已具备上市销售条件。公司公告汇总浙江海正药业股份有限公司关于子公司获得兽药产品批准文号批件的公告浙江海正药业股份有限公司控股子公司浙江海正动物保健品有限公司收到农业农村部核准签发的替米沙坦内服溶液（猫用）兽药产品批准文号批件，批准文号为兽药字110803434，有效期至2031年10月7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","BK0188","600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674850675","title":"海正药业（600267）披露子公司获得兽药产品批准文号批件，10月9日股价上涨2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674850675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674850675?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:22","pubTimestamp":1791555740,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，海正药业报收于11.94元，较前一交易日上涨2.58%，最新总市值为140.92亿元。近日，浙江海正药业股份有限公司发布《关于子公司获得兽药产品批准文号批件的公告》。公告显示，公司控股子公司浙江海正动物保健品有限公司收到农业农村部核准签发的替米沙坦内服溶液（猫用）兽药产品批准文号批件，批准文号为兽药字110803434，有效期至2031年10月7日。该产品用于治疗猫慢性肾病引起的蛋白尿，已具备上市销售条件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900038398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267","BK0060","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671254728","title":"股市必读：海正药业新发布《简式权益变动报告书（金浦浙展）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254728","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671254728?lang=zh_cn&edition=full","pubTime":"2026-09-29 02:08","pubTimestamp":1790618895,"startTime":"0","endTime":"0","summary":"本次权益变动后，金浦浙展持有上市公司6.16%股份，资金来源为其合伙人实缴出资。转让后公司第一大股东不变，不导致控制权变更。简式权益变动报告书浙江省国际贸易集团有限公司拟通过公开征集协议转让方式，将其持有的浙江海正药业股份有限公司72,673,907股无限售A股流通股转让给金浦浙展股权投资（丽水）合伙企业。本次权益变动尚需履行国有股权管理信息系统备案、上交所合规性确认及中登公司过户登记等程序。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900001990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600267","BK0028","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670060235","title":"海正药业（600267）披露持股5%以上股东协议转让股份提示性公告，9月28日股价上涨0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670060235","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670060235?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:56","pubTimestamp":1790589370,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，海正药业报收于11.54元，较前一交易日上涨0.96%，最新总市值为136.2亿元。近日，浙江海正药业股份有限公司发布《关于持股5%以上股东通过公开征集转让方式协议转让公司股份的结果暨与受让方签订〈股份转让协议〉的提示性公告》。本次转让需履行国有股权管理信息系统备案、上交所合规性确认及股份过户登记等程序，尚未完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800023828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600267","BK0028","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409867","title":"股市必读：海正药业新发布《简式权益变动报告书（金浦浙展）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409867?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:13","pubTimestamp":1790529188,"startTime":"0","endTime":"0","summary":"本次权益变动后，金浦浙展持有上市公司6.16%股份，资金来源为其合伙人实缴出资。转让后公司第一大股东不变，不导致控制权变更。简式权益变动报告书浙江省国际贸易集团有限公司拟通过公开征集协议转让方式，将其持有的浙江海正药业股份有限公司72,673,907股无限售A股流通股转让给金浦浙展股权投资（丽水）合伙企业。本次权益变动尚需履行国有股权管理信息系统备案、上交所合规性确认及中登公司过户登记等程序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","600267","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794061643428,"stockEarnings":[{"period":"1week","weight":0.0347},{"period":"1month","weight":0.1404},{"period":"3month","weight":0.0221},{"period":"6month","weight":0.1839},{"period":"1year","weight":0.2464},{"period":"ytd","weight":0.3826}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江海正药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"56005人(较上一季度增加14.70%)","perCapita":"21074股","listingDate":"2000-07-25","address":"浙江省台州市椒江区外沙路46号","registeredCapital":"118027万元","survey":" 浙江海正药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是海博麦布片（赛斯美）、注射用哌拉西林钠他唑巴坦钠（特治星）、盐酸米诺环素胶囊（玫满）、茚达特罗格隆溴铵吸入粉雾剂（杰润）、注射用丝裂霉素、瑞舒伐他汀钙片（海舒严）、注射用亚胺培南西司他丁钠（俊特）、米尔贝肟吡喹酮片（海乐妙）、丁二磺酸腺苷蛋氨酸肠溶片（喜美欣）、英夫马芬净。","listedPrice":11.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海正药业,600267,海正药业股票,海正药业股票老虎,海正药业股票老虎国际,海正药业行情,海正药业股票行情,海正药业股价,海正药业股市,海正药业股票价格,海正药业股票交易,海正药业股票购买,海正药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}